MASH WITH FIBROSIS
Clinical trials for MASH WITH FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MASH WITH FIBROSIS trials appear
Sign up with your email to follow new studies for MASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old heart drug could be new hope for millions with fatty liver
Disease control Recruiting nowThis study is testing if digoxin, a medication used for heart conditions, can help treat a serious liver disease called NASH (now called MASH). Researchers will give 144 people with NASH either digoxin or a placebo pill daily for 24 weeks to see if it reduces liver inflammation a…
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial tests new drug to halt scarring in fatty liver disease
Disease control Recruiting nowThis large, late-stage study is testing whether the drug efruxifermin can help people with a serious form of fatty liver disease called NASH or MASH, which causes liver inflammation and scarring. It will enroll 1,650 adults with moderate to advanced liver scarring but not full ci…
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC